In the light of the opioid epidemic, there has been growing interest in alternative care bundles for pain management, including cannabinoids as potential treatment to decrease opioid prescribing. Despite the lack of solid evidence on the efficacy of cannabinoids, their use among patients with pain, including those using opioids, is currently increasing. This use is supported by data suggesting that cannabinoids could potentially contribute to a better pain management and to a reduction in opioid doses while maintaining effective analgesia with minimum side effects. The scientific basis for supporting the use of cannabis is extensive, although it does not necessarily translate into relevant clinical outcomes. The use of cannabinoids in acute pain did not always consistently show statistically significant results in improving acute pain. Large randomized, controlled trials evaluating diverse cannabis extracts are needed in different clinical pain populations to determine safety and efficacy.
Keyphrases
- pain management
- chronic pain
- liver failure
- respiratory failure
- randomized controlled trial
- drug induced
- healthcare
- emergency department
- clinical trial
- palliative care
- hepatitis b virus
- machine learning
- intensive care unit
- big data
- study protocol
- artificial intelligence
- deep learning
- smoking cessation
- health insurance